|
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer
|
5R01CA157372-04
|
$528,829
|
|
THAKUR, MATHEW
|
THOMAS JEFFERSON UNIVERSITY
|
|
VIRUS DISCOVERY AND CHARACTERIZATION IN LARGE-SCALE CANCER SEQUENCING DATA
|
5R01CA178383-02
|
$202,685
|
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
Viral Oncology Training Grant
|
3T32CA009111-38S1
|
$13,628
|
$1,363
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-39
|
$387,094
|
$38,709
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$9,000
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$939,523
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer
|
5F30CA171715-04
|
$37,308
|
|
LOU, DIANNE
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
$108,798
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
University of Minnesota Building Interdisciplinary Research Careers in Women's He
|
5K12HD055887-09
|
$100,000
|
|
Raymond, Nancy
|
UNIVERSITY OF MINNESOTA
|
|
Understanding the context-dependent roles of mutations in lymphoma.
|
5R01CA136895-07
|
$286,200
|
|
DAVE, SANDEEP
|
DUKE UNIVERSITY
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
5U01CA164973-04
|
$3,879,211
|
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
UNC Oncology Clinical Translational Research Training Program
|
5K12CA120780-09
|
$135,139
|
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
1U54CA221208-01
|
$731,876
|
$263,475
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-04
|
$1
|
$1
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UCLA SPORE in Prostate Cancer
|
5P50CA092131-13
|
$2,185,000
|
|
REITER, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Tumor Immunology Training Program
|
5T32CA115308-08
|
$317,827
|
|
DJEU, JULIE
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-02
|
$315,400
|
|
HORUZSKO, ANATOLIJ
|
GEORGIA REGENTS UNIVERSITY
|
|
TransNet: Developing a Research Agenda in Transgender Health and Medicine
|
1R13HD084267-01
|
$5,000
|
|
FELDMAN, JAMIE
|
UNIVERSITY OF MINNESOTA
|
|
Transcriptional Regulation of Breast Cancer Metastasis within the Tumor Microenvi
|
5R21CA188799-02
|
$194,271
|
|
YATES, CLAYTON
|
TUSKEGEE UNIVERSITY
|
|
Training Program in Signal Transduction and Cancer
|
5T32CA070085-19
|
$216,281
|
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Training in Tumor Virology
|
2T32CA115299-11
|
$369,654
|
$73,931
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Training In Tumor Virology
|
3T32CA115299-10S1
|
$3,684
|
$737
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Training in Research for Behavioral Oncology and Cancer Control Program
|
5R25CA117865-10
|
$206,816
|
|
CHAMPION, VICTORIA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Tobacco Control in a Rapidly Changing Media Environment
|
5U01CA154254-05
|
$1,386,547
|
|
EMERY, SHERRY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Therapeutic In Situ Vaccination for Human Lymphoma
|
5R01CA188005-02
|
$311,682
|
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
1U54CA221204-01
|
$670,280
|
$341,843
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
The role of viral and cellular miRNAs in B-cell lymphomagenesis
|
5K99CA175181-02
|
$99,351
|
|
SKALSKY, REBECCA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer
|
5R01CA160558-04
|
$291,169
|
|
HU, WENWEI
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
|
5R01CA184283-02
|
$512,013
|
|
COBBS, CHARLES
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
The role of Aurora Kinase A in Upper Gastrointestinal Adenocarcinomas
|
5R01CA131225-07
|
$353,250
|
|
EL-RIFAI, WAEL
|
VANDERBILT UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$2,044
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$578
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-21
|
$4,814,560
|
$48,146
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$48,657
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Response to a Site-Specific Blocked DNA Replication Fork in Human Cancers
|
5R01CA187069-02
|
$364,993
|
|
POWELL, SIMON
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The National Person-Centered Assessment Resource (PCAR)
|
5U2CCA186878-02
|
$484,774
|
|
CELLA, DAVID
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors
|
5R01CA163103-05
|
$553,871
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Challenge of Individualizing Treatments for Patients with Breast Cancer
|
5P01CA163233-04
|
$2,543,942
|
|
KATZ, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
TCR/DAP10 chimera as a means to attaining persistent anti-tumor T cell responses
|
5R21CA181899-02
|
$197,055
|
|
GUEVARA-PATINO, JOSE
|
LOYOLA UNIVERSITY CHICAGO
|
|
Targeting tumor-microenvironment interaction to overcome leukemia chemoresistance
|
5F31CA183405-02
|
$43,120
|
|
SOTO-FELICIANO, YADIRA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-02
|
$423,409
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Targeting Neural Mitochondria to Treat Chemotherapy-Induced Peripheral Neuropathy
|
5R21CA183736-02
|
$174,000
|
|
HEIJNEN, COBI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-03
|
$377,438
|
$377,438
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
TARGETING INOS TO INHIBIT MYELOID-DERIVED SUPPRESSOR CELLS (MDSC) IN MELANOMA
|
5K08CA154963-05
|
$134,865
|
|
SIKORA, ANDREW
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting epigenetic regulators using bacterial macromolecule delivery
|
5R01CA188382-02
|
$311,561
|
|
FORBES, NEIL
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
|
5P01CA163200-04
|
$1,221,579
|
|
EIBL, GUIDO
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Targeted Therapies in Melanoma
|
5P01CA114046-08
|
$2,485,489
|
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-07
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeted Sphingolipid Metabolism for Treatment of AML
|
7P01CA171983-03
|
$2,077,502
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
Total relevant funding to Kaposi Sarcoma for this search: $31,644,719
|